| 수집원 | 발생값 ↓ | 관측 가능 시각 | 법인 | 회사명 | 사업연도 | 기간 | 연결구분 | 재무제표 | 계정명 | 표준 지표 | 금액 | 기준일 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | OFS | IS | 당기순이익(손실) | net_income | 1조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | OFS | BS | 자본금 | capital_stock | 8761억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | IS | 총포괄손익 | comprehensive_income | 5.6조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | IS | 영업이익 | operating_income | 5807.5억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | OFS | IS | 당기순이익(손실) | net_income | 3960.1억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | OFS | IS | 법인세차감전 순이익 | pretax_income | 3536억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | IS | 당기순이익(손실) | net_income | 2.5조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | CFS | BS | 자본금 | capital_stock | 8761억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 6405.9억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 3.5조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | CFS | BS | 이익잉여금 | retained_earnings | 5.2조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 자본금 | capital_stock | 1157.2억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | IS | 영업이익 | operating_income | 2.5조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 이익잉여금 | retained_earnings | 7.3조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:09 | — | SK이노베이션 | 2,026 | Q1 | CFS | BS | 자본총계 | total_equity | 38.1조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 유동부채 | current_liabilities | 2.7조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | IS | 매출액 | revenue | 45.9조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 비유동부채 | non_current_liabilities | 1.3조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:02 | — | POSCO홀딩스 | 2,026 | Q1 | OFS | BS | 부채총계 | total_liabilities | 4.2조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | CFS | BS | 이익잉여금 | retained_earnings | 16.1조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | CFS | IS | 매출액 | revenue | 36.7조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | CFS | IS | 영업이익 | operating_income | 3.6조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | BS | 자본총계 | total_equity | 132.2조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | CFS | IS | 총포괄손익 | comprehensive_income | 11.5조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | OFS | BS | 비유동자산 | non_current_assets | 24조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | OFS | BS | 자산총계 | total_assets | 27.4조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 부채총계 | total_liabilities | 4조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 자본총계 | total_equity | 7.9조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | IS | 당기순이익(손실) | net_income | 1.5조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | BS | 이익잉여금 | retained_earnings | 102.9조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | IS | 총포괄손익 | comprehensive_income | 1.5조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:13 | — | SK | 2,026 | Q1 | OFS | IS | 총포괄손익 | comprehensive_income | 9044억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:02 | — | POSCO홀딩스 | 2,026 | Q1 | OFS | BS | 자산총계 | total_assets | 52.7조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | BS | 자본금 | capital_stock | 1.4조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | IS | 법인세차감전 순이익 | pretax_income | 2조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 유동자산 | current_assets | 4.6조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | CFS | BS | 부채총계 | total_liabilities | 43.7조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | CFS | BS | 비유동부채 | non_current_liabilities | 9.5조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | BS | 자본총계 | total_equity | 7.4조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | BS | 부채총계 | total_liabilities | 251.6조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | IS | 매출액 | revenue | 4.5조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:02 | — | POSCO홀딩스 | 2,026 | Q1 | OFS | BS | 유동부채 | current_liabilities | 5065.9억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:11:56 | — | 현대자동차 | 2,026 | Q1 | CFS | BS | 비유동부채 | non_current_liabilities | 155.4조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | FY | OFS | IS | 영업이익 | operating_income | 2조원 | 2025-12-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:08 | — | 현대모비스 | 2,026 | Q1 | CFS | IS | 영업이익 | operating_income | 8026.4억원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | OFS | BS | 유동자산 | current_assets | 21조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:08 | — | 현대모비스 | 2,026 | Q1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 1.2조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | CFS | BS | 자본총계 | total_equity | 61.6조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:03 | — | 기아 | 2,026 | Q1 | CFS | BS | 이익잉여금 | retained_earnings | 53.7조원 | 2026-03-31 |
| dart-financials | 2026-05-15 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,026 | Q1 | CFS | BS | 비유동자산 | non_current_assets | 7.3조원 | 2026-03-31 |